Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA ephedra appeal

This article was originally published in The Tan Sheet

Executive Summary

FDA is expected to submit an opening brief in mid-August to appeal a Utah court's April decision to overturn the agency's ephedra ban. A notice of appeal was filed by FDA in 10th Circuit Court of Appeals June 13 and a court docket opened for the appeal indicates initial filings are due July 7. The Utah court ruled that plaintiff Nutraceutical Corp. could continue selling its product containing 10 mg of ephedra (1"The Tan Sheet" April 18, 2005, p. 5)...
Advertisement

Related Content

Utah Court Overturns Ephedra Ban For Low-Dose Products
Utah Court Overturns Ephedra Ban For Low-Dose Products

Topics

Advertisement
UsernamePublicRestriction

Register

PS098351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel